Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

67 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-28

Study Completion Date

2020-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiac rehabilitation after an acute coronary syndrome is recognised in the latest guidelines and recommendations published by the major scientific societies as a class I indication. Despite this evidence, the number of patients entering such programmes in Europe is still around 30%. The present study aims to validate a new comprehensive Telerehabilitation System to provide support for cardiac rehabilitation, to optimize it and to test its usefulness in terms of improving adherence to physical exercise and cardiovascular risk parameters.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Early Home-based Cardiac Rehabilitation Program for Patients After Acute Myocardial Infarction

NCT02584192

Acute Myocardial Infarction

COMPLETED NA

Characteristics and Consequences of Coronary Angiograms Performed in Intensive Care Patients

NCT05529810

Acute Coronary Syndrome

COMPLETED

Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI

NCT00487812

Ischemic Heart Disease Myocardial Infarction

COMPLETED NA

Coronary Arteriosclerosis in Patients With Acute Ischemic Stroke

NCT00701818

Ischemic Stroke Myocardial Ischemia Coronary Arteriosclerosis

COMPLETED

High-sensitivity Troponin T in Acute Myocardial Infarction After Cardiac Valvular Surgery

NCT02518282

Acute Myocardial Infarction Disorder; Heart, Functional, Postoperative, Cardiac Surgery Myocardial Infarction +1 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To validate this approach, a clinical trial was designed to compare a 10-month program of cardiac telerehabilitation with a conventional 8-week centre-based cardiac rehabilitation. Seventy patients will be randomized 1:1 to cardiac telemonitoring or centre-based cardiac rehabilitation. The characteristics of the interventions do not allow the study to be blinded to the patient or the professional. However, the analyses, stress tests and questionaires will be carried out in a masked form without the assigned group being identified by the researchers carrying out the examinations. Assessment for primary and main secondary outcomes will be performed at baseline and at ten months of follow-up, and will include self-reported physical activity (IPAQ), VO2max, blood test, general emotional distress, Adherence to the Mediterranean Diet, quality of life, vital signs, returning to work. The hypothesis is that patients randomised to prolonged telemonitoring will demonstrate higher levels of physical activity at 10-month follow-up, compared to patients in the centre-based cardiac rehabilitation programme, as well other positive changes in the cardiovascular risk profile.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Angina, Unstable Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) ST-segment Elevation Myocardial Infarction (STEMI)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Phase III clinical trial, feasibility, controlled and randomized, with two arms: cardiac telerehabilitation (intervention group) and centre-based cardiac rehabilitation (control group)

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Caregivers

The characteristics of the interventions do not allow the study to be blinded either for the patient or for the professional. However, the analyses, stress tests and shuttle tests will be performed in a masked manner without the assigned group being identified by the investigators who carry out the examinations.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cardiac tele-rehabilitation

Patients in the Intervention Group will come to the hospital 4 times during two consecutive weeks, undergoing physical exercise sessions and the same educational talks as in the control group. Subsequently, they will follow the scheduled physical activities and adherence to the risk factor management according to individualised guidelines in their App, until the end of the study period. All data generated are recorded on the professional website. The degree of compliance with the objectives set is monitored by means of 7 coloured icons, which vary according to the target achievement.

Group Type EXPERIMENTAL

telemonitoring

Intervention Type DEVICE

The system consists of the following elements:

1. Professional website at the hospital, which allows:

* To set up an individualised care plan
* To establish the patient's risk profile and targets for improvement.
* Long-term monitoring of the evolution of cardiovascular risk factors and events that occurred
* Advise the patient on self-management strategies.
2. Mobile application software with the following functions:

* Scheduled exercise sessions
* Medication reminder
* Measurement reminder (weight, blood pressure, heart rate, waist circumference, etc.)
* Messages: Inbox folder for system messages and messages generated by professionals for a specific patient or video conference.
* Training monitor: guides the patient in the performance of their exercise.
* Access to certified health information for patients

Centre-based cardiac rehabilitation

Patients in the control group will come to the hospital 16 times during eight weeks for cycling and muscle strengthening exercises. Educational talks will be given. At the end of the hospital phase, a conventional outpatient follow-up by primary care and the corresponding specialist will be carried out.

Group Type ACTIVE_COMPARATOR

Centre-based cardiac rehabilitation

Intervention Type OTHER

The physical activity consisted of a workout routine and aerobic cycling training. Patients are instructed to perform 150 minutes per week of moderate physical activity when the hospital phase finishes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

telemonitoring

The system consists of the following elements:

1. Professional website at the hospital, which allows:

* To set up an individualised care plan
* To establish the patient's risk profile and targets for improvement.
* Long-term monitoring of the evolution of cardiovascular risk factors and events that occurred
* Advise the patient on self-management strategies.
2. Mobile application software with the following functions:

* Scheduled exercise sessions
* Medication reminder
* Measurement reminder (weight, blood pressure, heart rate, waist circumference, etc.)
* Messages: Inbox folder for system messages and messages generated by professionals for a specific patient or video conference.
* Training monitor: guides the patient in the performance of their exercise.
* Access to certified health information for patients

Intervention Type DEVICE

Centre-based cardiac rehabilitation

The physical activity consisted of a workout routine and aerobic cycling training. Patients are instructed to perform 150 minutes per week of moderate physical activity when the hospital phase finishes.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent
* Patients after uncomplicated acute coronary syndrome of both sexes.
* Patients completing a maximal or symptom-limited CPET without angina or electrical ischaemia.
* Age equal to or less than 72 years.

Exclusion Criteria

* Refusal of informed consent
* Advanced biological age.
* Kidney failure (GFR \< 30ml/min/1.73 m2).
* Liver failure (GOT \>2 times normal value).
* Ejection fraction less than 50%.
* Uncontrolled blood pressure (\>140/90 mmHg).
* Uncontrolled heart failure.
* Dissecting aortic aneurysm.
* Uncontrolled ventricular tachycardia or other dangerous ventricular arrhythmias.
* Aortic or mitral valve disease.
* Recent systemic or pulmonary embolism.
* Active or recent thrombophlebitis.
* Acute infectious diseases.
* Uncontrolled supraventricular arrhythmias or tachycardia.
* Repeated or frequent ventricular ectopic activity.
* Moderate pulmonary hypertension.
* Ventricular aneurysm.
* Uncontrolled diabetes, thyrotoxicosis, myxedema,
* Conduction disorders such as: complete atrioventricular block. Left bundle branch block.
* Wolf-Parkinson-White syndrome.
* Fixed rate pacing.
* Severe anaemia.
* Psychoneurotic disorders.
* Neuromuscular, musculoskeletal and arthritic disorders that may limit activity. may limit activity.

Minimum Eligible Age

18 Years

Maximum Eligible Age

72 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No